Medical Prognosis Institute A/S (MPI):企業の財務・戦略的SWOT分析

◆英語タイトル:Medical Prognosis Institute A/S (MPI) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15148
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥39,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medical Prognosis Institute A/S (MPI) is a precision medicine provider that offers cancer treatment solutions. The company offers drug response prediction platforms that provide tools for rationalized drug development and personalized medicine. It offers lead compound selection, drug rescue repositioning repurposing, patient selection, drug combinations, pathway elucidation, new indications, indication selection and companion diagnostic programs. MPI also offers drug specific interface to the human genome and predict drug response in individual patients. The company has partnerships with various cancer drug developing companies. It operates in Denmark and the US. MPI is headquartered in Horsholm, Denmark.

Medical Prognosis Institute A/S Key Recent Developments

Jul 02,2018: Oncology Venture Sweden: Strong LiPlaCis Treatment Results in DRP-Selected Breast Cancer Patients Collaborative LiPlaCis Regulatory Meeting with DKMA
Jul 02,2018: MPI – Strong LiPlaCis Treatment Results in DRP-Selected Breast Cancer Patients – Collaborative LiPlaCis Regulatory Meeting with DKMA
May 31,2018: MPI – Change in Board of directors
Mar 23,2018: MPI publishes Annual report for 2017
Mar 13,2018: Medical Prognosis Institute publishes selected financial information for the period 1 July 2017 – 31 December 2017 due to the proposed merger between Medical Prognosis Institute and Oncology Venture

This comprehensive SWOT profile of Medical Prognosis Institute A/S provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Medical Prognosis Institute A/S including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Medical Prognosis Institute A/S – Key Information
Medical Prognosis Institute A/S – Overview
Medical Prognosis Institute A/S – Key Employees
Medical Prognosis Institute A/S – Key Employee Biographies
Medical Prognosis Institute A/S – Key Operational Heads
Medical Prognosis Institute A/S – Major Products and Services
Medical Prognosis Institute A/S – History
Medical Prognosis Institute A/S – Company Statement
Medical Prognosis Institute A/S – Locations And Subsidiaries
Medical Prognosis Institute A/S – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Medical Prognosis Institute A/S – Business Description
Medical Prognosis Institute A/S – Corporate Strategy
Medical Prognosis Institute A/S – SWOT Analysis
SWOT Analysis – Overview
Medical Prognosis Institute A/S – Strengths
Medical Prognosis Institute A/S – Weaknesses
Medical Prognosis Institute A/S – Opportunities
Medical Prognosis Institute A/S – Threats
Medical Prognosis Institute A/S – Key Competitors

Section 3 – Company Financial Performance Charts

Medical Prognosis Institute A/S – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Medical Prognosis Institute A/S, Key Information
Medical Prognosis Institute A/S, Key Ratios
Medical Prognosis Institute A/S, Share Data
Medical Prognosis Institute A/S, Major Products and Services
Medical Prognosis Institute A/S, History
Medical Prognosis Institute A/S, Key Employees
Medical Prognosis Institute A/S, Key Employee Biographies
Medical Prognosis Institute A/S, Key Operational Heads
Medical Prognosis Institute A/S, Other Locations
Medical Prognosis Institute A/S, Subsidiaries
Medical Prognosis Institute A/S, Key Manufacturing facilities
Medical Prognosis Institute A/S, Key Competitors
Medical Prognosis Institute A/S, SWOT Analysis
Medical Prognosis Institute A/S, Ratios based on current share price
Medical Prognosis Institute A/S, Annual Ratios
Medical Prognosis Institute A/S, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Medical Prognosis Institute A/S, Performance Chart
Medical Prognosis Institute A/S, Ratio Charts

★海外企業調査レポート[Medical Prognosis Institute A/S (MPI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • LeMaitre Vascular Inc (LMAT):製品パイプライン分析
    Summary LeMaitre Vascular Inc (LeMaitre Vascular) is a medical device company. It undertakes the development, manufacture, marketing and sale of devices that are used in the treatment of peripheral vascular diseases. The company offers several product lines for vascular surgery and endovascular proc …
  • Qatar Electricity & Water Co QPSC (QEWS):電力:M&Aディール及び事業提携情報
    Summary Qatar Electricity & Water Co QPSC (QEWC), formerly Qatar Electricity & Water Company QSC, is an electricity and water utility. It generates electricity and desalinates water. The company owns and operates various power generation and water desalination stations and substations primarily in Q …
  • McLean Electric Cooperative Inc:企業の戦略的SWOT分析
    McLean Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • M. A. Mortenson Co:戦略・SWOT・企業財務分析
    M. A. Mortenson Co - Strategy, SWOT and Corporate Finance Report Summary M. A. Mortenson Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • The Hain Celestial Group, Inc.:戦略・SWOT・企業財務分析
    The Hain Celestial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Hain Celestial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Jefferies Group LLC:企業のM&A・事業提携・投資動向
    Jefferies Group LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Jefferies Group LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Kyivstar JSC:企業の戦略的SWOT分析
    Kyivstar JSC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Culture Landmark Investment Ltd:企業の戦略・SWOT・財務分析
    Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report Summary Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Metabolomic Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Metabolomic Technologies Inc (MTI) is a diagnostic company that develops metabolomic-based diagnostic systems. The company's products comprise ColoDx, PolypDx, BreastDx, ProstateDx, CeliacDx, ColitisDx, CrohnsDx and other products. Its products develop advanced diagnostic tests for gastroint …
  • Brain Resource Ltd (BRC):企業の財務・戦略的SWOT分析
    Summary Brain Resource Ltd (BRL) is a healthcare service provider that offers therapies. The company carries out research and development of brain products. Its products comprise iSPOT, Total Brain and MyBrainSolutions. BRL’s MyBrainSolutions is a brain health solution to know and train brain for pe …
  • RegeneRx Biopharmaceuticals Inc (RGRX):企業の財務・戦略的SWOT分析
    Summary RegeneRx Biopharmaceuticals Inc (RegeneRx) is a clinical-stage biopharmaceutical company that designs, researches and develops novel peptides targeted at diseases with unmet medical needs. The company offers clinical trials, science and discovery and business development services. Its busine …
  • Rockwell Automation Inc (ROK):電力:M&Aディール及び事業提携情報
    Summary Rockwell Automation Inc (Rockwell) is a provider of industrial automation power, control and information systems. The company offers connected components, midrange architecture system, asset and consultancy management; engineered packages and panels integration; front end engineering and des …
  • InTouch Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary InTouch Technologies Inc (InTouch Health) is a healthcare technology company that provides Telehealth Network, comprised of telehealth systems, clinical workflow solutions, software and managed services to healthcare systems and hospitals for the delivery of clinical care. The company’s tele …
  • Energy XXI Gulf Coast Inc (EXXIQ):企業の財務・戦略的SWOT分析
    Summary Energy XXI Gulf Coast Inc (Energy XXI) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include West Delta, South Timbalier, South Pass, Main Pass, and Ship Shoal. Its West Delta property is located 28 miles offshore of Grand Isle, Louis …
  • Paysafe Group Plc:企業の戦略的SWOT分析
    Paysafe Group Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • PT Sinar Mas Agro Resources and Technology Tbk (SMAR):企業の財務・戦略的SWOT分析
    PT Sinar Mas Agro Resources and Technology Tbk (SMAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s …
  • Tessco Technologies Incorporated (TESS):企業の財務・戦略的SWOT分析
    Tessco Technologies Incorporated (TESS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • First Solar Inc (FSLR):電力:M&Aディール及び事業提携情報
    Summary First Solar Inc (First Solar) is a provider of comprehensive photovoltaic (PV) solar systems. It designs, manufactures, and sells PV solar modules. The company produces solar systems using cadmium telluride technology. First Solar also develops, designs, constructs, and sells PV solar power …
  • Megapharm Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Megapharm Ltd (Megapharm) is a biotechnology company that offers marketing of pharmaceutical products for international companies. The company markets products in therapeutic areas such as central nervous system, dermatology, gastroenterology, urology, respiratory and allergy, oncology, rheu …
  • Sejal Glass Limited (SEZAL):企業の財務・戦略的SWOT分析
    Sejal Glass Limited (SEZAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆